Characteristics | HRD status Negative vs positive | P value | |
---|---|---|---|
Odds ratio | 95%CI | ||
Age(year) | 0.97 | 0.93–1.01 | 0.176 |
BMI (kg/m2) | 0.92 | 0.77–1.10 | 0.374 |
Family history | |||
 No | Ref |  |  |
 Yes | 2.06 | 0.81–5.62 | 0.141 |
Marital status | |||
 Unmarried | Ref |  |  |
 Married | 0.43 | 0.02–3.48 | 0.469 |
Menopause | |||
 Premenopausal |  |  |  |
 Menopause | 1.23 | 0.44–3.68 | 0.694 |
Side classification | |||
 Left | Ref |  |  |
 Right | 2.30 | 0.99–5.49 | 0.055 |
 Both | NC | NC | 0.990 |
Pathological type | |||
 Invasive cancer | Ref |  |  |
 DCIS | NC | NC | 0.98 |
Grade | |||
 1 | NC | NC | NC |
 2 | Ref |  |  |
 3 | 3.07 | 1.23–8.12 | 0.019* |
 Others | 6.00 | 0.89–119.01 | 0.112 |
ER | |||
 Negative | Ref |  |  |
 Positive | 0.32 | 0.13–0.77 | 0.011* |
PR | |||
 Negative |  |  |  |
 Positive | 0.32 | 0.13–0.78 | 0.014* |
HER2 | |||
 Negative | Ref |  |  |
 Low or positive | 0.36 | 0.15–0.84 | 0.019* |
Molecular subtype | |||
 Luminal A | Ref |  |  |
 Luminal B | 2.00 | 0.22–43.12 | 0.568 |
 Triple-negative | 6.50 | 0.77–136.50 | 0.116 |
 HER- 2 overexpression | 3.00 | 0.07–170.77 | 0.547 |
T stage | |||
 Tis- 1 | Ref |  |  |
 2–4 | 1.52 | 0.63–3.68 | 0.349 |
N stage | |||
 0 | Ref |  |  |
 1–3 | 0.81 | 0.35–1.85 | 0.611 |
M stage | |||
 0 | Ref |  |  |
 1 | 1.37 | 0.38–5.57 | 0.636 |
Stage | |||
 0–II | Ref |  |  |
 III–IV | 1.20 | 0.50–2.95 | 0.686 |
CEA (ng/ml) | 0.90 | 0.73–1.08 | 0.271 |
CA- 125 (U/ml) | 1.00 | 1.00–1.01 | 0.430 |
CA153 (U/ml) | 1.01 | 0.99–1.04 | 0.484 |
Ki- 67 | 32.18 | 4.22–306.29 | 0.001** |